Related Experiment Video

Updated: Dec 19, 2025

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
06:52

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages

Published on: May 21, 2018

11.1K

Inflammasomes and Pyroptosis as Therapeutic Targets for COVID-19

Jeremy K Y Yap1, Miyu Moriyama2, Akiko Iwasaki3,4,5

  • 1School of Postgraduate Studies, International Medical University, 57000 Kuala Lumpur, Malaysia.

Journal of Immunology (Baltimore, Md. : 1950)
|June 5, 2020
PubMed

Insights

The inflammasome pathway is crucial in severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infections, impacting COVID-19 outcomes. Targeting inflammasome activation offers a promising therapeutic strategy for severe COVID-19-associated diseases.

Area of Science:

  • Immunology
  • Virology
  • Pharmacology

Background:

  • Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infection triggers significant inflammatory responses.
  • The inflammasome pathway plays a critical role in the innate immune response to SARS-CoV-2.
  • Inflammasome activation leads to pyroptosis and cytokine release, contributing to severe COVID-19 pathology.

Purpose of the Study:

  • To highlight the significance of the inflammasome pathway in SARS-CoV-2 infection.
  • To explore pharmaceutical agents targeting inflammasome activation for COVID-19 treatment.
  • To identify potential therapeutic strategies for severe COVID-19-associated diseases.

Main Methods:

  • Review of innate immune pathways engaged by SARS-CoV-2.
  • Focus on the inflammasome pathway and its components.
  • Discussion of pharmaceutical agents targeting inflammasome signaling.

Main Results:

  • The inflammasome pathway is a key mediator of the inflammatory response in SARS-CoV-2 infection.
  • Targeting inflammasome activation, pyroptosis, and downstream cytokines shows therapeutic potential.
  • Pharmaceutical agents offer promising avenues for treating severe COVID-19.

Conclusions:

  • The inflammasome pathway is a critical therapeutic target for severe COVID-19.
  • Modulating inflammasome-driven inflammation could improve clinical outcomes.
  • Further research into inflammasome inhibitors is warranted for COVID-19 treatment.

More Related Videos

Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum06:12

Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum

Published on: May 3, 2024

3.0K
Evaluation of Caspase Activation to Assess Innate Immune Cell Death10:23

Evaluation of Caspase Activation to Assess Innate Immune Cell Death

Published on: January 20, 2023

3.7K

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
7.8K
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
13.5K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
4.7K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.0K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
9.7K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
9.0K